258 related articles for article (PubMed ID: 37452329)
21. Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension.
Murthy PB; Naidu S; Davaro F; Spiess PE; Zemp L; Poch M; Jain R; Vosoughi A; Grass GD; Yu A; Sexton WJ; Gilbert SM; Li R
Curr Oncol; 2023 Mar; 30(3):3223-3231. PubMed ID: 36975458
[TBL] [Abstract][Full Text] [Related]
22. Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study.
Santos F; Dragomir A; Kassouf W; Franco EL; Aprikian A
BJU Int; 2015 Mar; 115(3):389-96. PubMed ID: 24656061
[TBL] [Abstract][Full Text] [Related]
23. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
[TBL] [Abstract][Full Text] [Related]
24. Predictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada.
Santos F; Dragomir A; Zakaria AS; Kassouf W; Aprikian A
J Surg Oncol; 2016 Feb; 113(2):223-8. PubMed ID: 26696270
[TBL] [Abstract][Full Text] [Related]
25. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
[TBL] [Abstract][Full Text] [Related]
26. Survival after radical cystectomy during holiday periods.
Liedberg F; Hagberg O; Aljabery F; Gårdmark T; Hosseini A; Jahnson S; Jerlström T; Malmström PU; Sherif A; Söderkvist K; Ströck V; Ullén A; Häggström C; Holmberg L
Scand J Urol; 2021 Aug; 55(4):276-280. PubMed ID: 34124994
[TBL] [Abstract][Full Text] [Related]
27. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG
Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169
[TBL] [Abstract][Full Text] [Related]
28. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder.
Stensland KD; Zaid H; Broadwin M; Sorcini A; Canes D; Galsky M; Moinzadeh A
Eur Urol Oncol; 2020 Aug; 3(4):509-514. PubMed ID: 31411987
[TBL] [Abstract][Full Text] [Related]
29. Does patient age affect survival after radical cystectomy?
Horovitz D; Turker P; Bostrom PJ; Mirtti T; Nurmi M; Kuk C; Kulkarni G; Fleshner NE; Finelli A; Jewett MA; Zlotta AR
BJU Int; 2012 Dec; 110(11 Pt B):E486-93. PubMed ID: 22551360
[TBL] [Abstract][Full Text] [Related]
30. The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study.
Wahafu W; Liu S; Xu W; Wang M; He Q; Song L; Wang M; Yang F; Hua L; Niu Y; Xing N
BMC Urol; 2019 Nov; 19(1):117. PubMed ID: 31733646
[TBL] [Abstract][Full Text] [Related]
31. Association between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes following Radical Cystectomy: Systematic Review and Meta-Analysis.
Cacciamani GE; Ghodoussipour S; Mari A; Gill KS; Desai M; Artibani W; Gill PS; Shariat SF; Gill IS; Djaladat H
J Urol; 2020 Oct; 204(4):649-660. PubMed ID: 32105187
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy.
Zhang S; Du J; Zhong X; Tan P; Xu H; Zhang J; Jin D; Li Y; Le W; Xiong X; Lin T; Wei Q
Front Immunol; 2022; 13():1072433. PubMed ID: 36524107
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
[TBL] [Abstract][Full Text] [Related]
35. Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.
Yao Z; Jiang Y; Zhu X; Wu B; Bai S
Int J Clin Oncol; 2020 Jul; 25(7):1377-1384. PubMed ID: 32318904
[TBL] [Abstract][Full Text] [Related]
36. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
[TBL] [Abstract][Full Text] [Related]
37. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
[TBL] [Abstract][Full Text] [Related]
38. Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada: BJU Int 2012;110(9):1317-23 [Epub 2012 Apr 13].
Kamat AM
Urol Oncol; 2013 Jul; 31(5):717-8. PubMed ID: 23796202
[TBL] [Abstract][Full Text] [Related]
39. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
Gakis G; Ngamsri T; Rausch S; Mischinger J; Todenhöfer T; Schwentner C; Schmid MA; Hassan FA; Renninger M; Stenzl A
World J Urol; 2015 Oct; 33(10):1429-37. PubMed ID: 25595732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
